By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.
Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.
Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.
A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.
November 30, 2023
📅 5th December – 1:30pm to 2:15pm (CET) 📍 On line via Gotowebinar 💶 Free but mandatory registration Register In Clinical Research, difficulties in recruiting subjects are one of the main causes of premature termination of clinical trials. Between 20 to 30% of clinical trials are affected by inclusion delays and more than 1 out of […]
November 30, 2023
Applied Clinical Trials Online Site and project management teams play major roles in risk-management and monitoring performance. As the modernization of clinical research through digital and decentralized solutions continues to take research into local communities, reduce patient and site burden, and increase diversity, it will lead to new ways of working for project delivery teams. […]
November 30, 2023
Applied Clinical Trials Online Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are. In a study published earlier this month by JAMA, the authors aimed to discover how the pharmaceutical industry gets involved in the most influential modern clinical trials and how they fare […]